Delivery Order SPE2DB20D9331-SPE2DB21FL1P1

Award Date 7/23/21
Potential Completion Date 7/26/21
Potential Value $35K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $30,043.74 firm fixed-price delivery order under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) for the Medical Supply Chain program. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $5,307.42, is for the supply of pharmaceutical products and medical supplies to support the Department of Defense's (DoD) medical facilities worldwide. The contract covers a wide range of items, including branded and generic prescription drugs, over-the-counter medications, biologics,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at $12,934.05, is for the delivery of a range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $1,786.44 firm fixed price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract. The contract is to provide the U.S. Department of Defense with a variety of pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military health facilities. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $74,135.50 firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, covers a comprehensive array of medications, including branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at up to $18,526.83, is a firm fixed-price delivery order with no set-aside designation. It covers the supply of various medications, including branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order with a ceiling value of $12,680.98. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to provide a wide range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a ceiling value of $10,093.50. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These supplies are intended to fulfill the recurring...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB21FL1P1
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Prime Vendor Pharmaceutical program. The contract, valued at $35,236.62, is for the supply of a wide range of pharmaceutical products and medical supplies to military health facilities worldwide. This includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price delivery orders for pharmaceutical items to meet the recurring medical supply needs of the Department of Defense (DoD) healthcare facilities.

Generated 1/9/25, 9:20 AM